[HTML][HTML] Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series
M Arboleda, S Barrantes, LY Úsuga… - Revista da Sociedade …, 2019 - SciELO Brasil
Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series.
M Arboleda, S Barrantes, LY Úsuga… - Revista da Sociedade …, 2019 - europepmc.org
Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
[PDF][PDF] Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series
M Arboleda, S Barrantes, LY Úsuga… - Journal of the Brazilian …, 2019 - academia.edu
Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series
M Arboleda, S Barrantes, LY Úsuga… - Rev. Soc. Bras. Med …, 2019 - pesquisa.bvsalud.org
Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
[PDF][PDF] Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series
M Arboleda, S Barrantes, LY Úsuga… - Journal of the Brazilian …, 2019 - scholar.archive.org
Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series
M Arboleda, S Barrantes, LY Úsuga, SM Robledo - sidalc.net
Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series
M Arboleda, S Barrantes, LY Úsuga… - Revista da …, 2019 - pubmed.ncbi.nlm.nih.gov
Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
[PDF][PDF] Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series
M Arboleda, S Barrantes, LY Úsuga… - Journal of the …, 2019 - pdfs.semanticscholar.org
Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series
M Arboleda, S Barrantes, LY Úsuga… - Revista da Sociedade …, 2019 - SciELO Brasil
Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: a case series.
M Arboleda, S Barrantes, L Yaned Úsuga, SM Robledo - 2019 - cabidigitallibrary.org
Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …
Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine …